Amann KU, Daniel C, Büttner-Herold M (2020)
Publication Type: Journal article
Publication year: 2020
DOI: 10.1007/s00292-020-00773-0
Increasing interest in the role of the complement system in systemic and renal disease is based on new pathophysiological and therapeutic insights of the recent past and particularly in genetic analyses in children with atypical hemolytic uremic syndrome (aHUS). aHUS is the prototypical systemic disease associated with excessive activation of the alternative complement pathway and manifests in the kidney, but also in other organs as thrombotic microangiopathy (TMA). Pathomechanisms discovered to induce the overactivation of the alternative complement pathway in aHUS led to the first successful therapeutic application of a C5b9 inhibitor. This suppression of the terminal complement cascade succeeded in inhibiting local tissue damage. Thereafter, thanks to advanced modern technologies, further systemic and renal diseases associated with mutations or auto-antibodies targeting the complement pathway were identified. Hereby, disease onset is frequently associated with an additional trigger, e.g. infection or hormonal alterations/imbalances, against the background of a pre-existing predisposition of the patient. Due to the growing understanding of the regulation, and thus the possibility of therapeutic modulation of the different complement pathways, and due to the increasing availability of a variety of drugs inhibiting the complement system, interest in complement-mediated systemic and renal disease has been steadily increasing, making it a "hot-topic" in medicine in recent years.
APA:
Amann, K.U., Daniel, C., & Büttner-Herold, M. (2020). The complement system-a "hot topic" not only for kidney diseases. Pathologe. https://doi.org/10.1007/s00292-020-00773-0
MLA:
Amann, Kerstin Ute, Christoph Daniel, and Maike Büttner-Herold. "The complement system-a "hot topic" not only for kidney diseases." Pathologe (2020).
BibTeX: Download